Multicenter Analysis of Effect of High Biologic Effective Dose on Biochemical Failure and Survival Outcomes in Patients With Gleason Score 7–10 Prostate Cancer Treated With Permanent Prostate Brachytherapy-Reference-Cited by-同舟云学术

Multicenter Analysis of Effect of High Biologic Effective Dose on Biochemical Failure and Survival Outcomes in Patients With Gleason Score 7–10 Prostate Cancer Treated With Permanent Prostate Brachytherapy

Published:2009-02 Issue:2 Volume:73 Page:341-346
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Stone Nelson N.,Potters Louis,Davis Brian J.,Ciezki Jay P.,Zelefsky Michael J.,Roach Mack,Shinohara Katsuto,Fearn Paul A.,Kattan Michael W.,Stock Richard G.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference29 articles.

1. Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era;D'Amico;J Clin Oncol,2003

2. Stage T1-2 prostate cancer: A multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy;Kupelian;Int J Radiat Oncol Biol Phys,1997

3. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): A phase III randomised trial;Bolla;Lancet,2002

4. Combined modality treatment in the management of high-risk prostate cancer;Stock;Int J Radiat Oncol Biol Phys,2004

5. 12-Year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer;Potters;J Urol,2005

Cited by 130 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term outcomes of high-dose-rate brachytherapy and external beam radiotherapy without hormone therapy for high-risk localized prostate cancer;Japanese Journal of Radiology;2024-06-29

2. What is the key factor determining effectiveness of radiotherapy for high-risk prostate cancer: a hidden message from RTOG 0521;Translational Andrology and Urology;2024-04

3. Trimodality Therapy With Iodine-125 Brachytherapy, External Beam Radiation Therapy, and Short- or Long-Term Androgen Deprivation Therapy for High-Risk Localized Prostate Cancer: Results of a Multicenter, Randomized Phase 3 Trial (TRIP/TRIGU0907);International Journal of Radiation Oncology*Biology*Physics;2024-02

4. Clinical Efficacy and Openness to New Challenges of Low Dose Rate Brachytherapy for Prostate Cancer;Current Oncology;2023-11-08

5. Determining Combined Modality Dosimetric Constraints by Integration of IMRT and LDR Prostate Brachytherapy Dosimetry and Correlation with Toxicity;Advances in Radiation Oncology;2023-05